tiprankstipranks
Trending News
More News >
ALS Ltd. (AU:ALQ)
ASX:ALQ

ALS (ALQ) AI Stock Analysis

Compare
25 Followers

Top Page

AU:ALQ

ALS

(Sydney:ALQ)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
AU$22.00
â–¼(-0.54% Downside)
ALS's strong financial performance is the most significant factor, supported by robust revenue growth and profitability. Technical analysis indicates a bullish trend, though caution is advised due to overbought signals. The valuation suggests the stock may be overvalued, which slightly offsets the positive financial and technical outlook.
Positive Factors
Revenue Growth
Consistent revenue growth indicates the company's expanding market reach and successful business model, supporting long-term stability.
Profitability
Improved profitability reflects efficient operations and cost management, enhancing the company's ability to reinvest and grow.
Cash Flow Generation
Strong cash flow generation supports operational needs and strategic investments, ensuring financial flexibility and resilience.
Negative Factors
Leverage Management
High leverage can limit financial flexibility and increase risk, potentially impacting the company's ability to invest and grow.
Operational Cost Pressures
Decreasing EBIT margins indicate rising operational costs, which could pressure profitability if not managed effectively.
Cash Conversion Efficiency
Inefficient cash conversion can hinder the company's ability to fund operations and growth, affecting long-term financial health.

ALS (ALQ) vs. iShares MSCI Australia ETF (EWA)

ALS Business Overview & Revenue Model

Company DescriptionALS Limited (ALQ) is a global company providing testing, inspection, certification, and advisory services across a variety of sectors, including mining, environmental, and food industries. The company is dedicated to delivering high-quality and reliable services that ensure compliance with industry standards and regulations. ALS operates in multiple geographical regions, leveraging its extensive laboratory network to support clients in making informed decisions based on accurate data.
How the Company Makes MoneyALS generates revenue through a diversified model that includes several key streams. Primarily, it earns money from laboratory testing services, where clients pay for the analysis of samples related to soil, water, air, and food safety. Additionally, the company provides inspection and certification services, which involve auditing and validating compliance with industry standards. ALS also offers technical consulting and advisory services, helping clients navigate regulatory frameworks and optimize their operations. Strategic partnerships with various industries enhance its service offerings and expand its client base, contributing to stable revenue growth. Seasonal fluctuations in demand for certain services can impact earnings, but the company's broad portfolio helps mitigate risks associated with specific market trends.

ALS Financial Statement Overview

Summary
ALS exhibits robust financial health with strong revenue growth and profitability. The balance sheet shows improved leverage, though it remains a point of attention. Cash flow generation is solid, supporting the company's operational and strategic initiatives.
Income Statement
85
Very Positive
ALS has demonstrated strong revenue growth with a 10.95% increase in the latest year, supported by a high gross profit margin of 89.80%. The net profit margin improved significantly to 8.54%, indicating enhanced profitability. However, the EBIT margin slightly decreased, suggesting some operational cost pressures.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has improved, indicating better leverage management, but remains relatively high. Return on equity is strong at 21.30%, reflecting efficient use of equity. The equity ratio is stable, suggesting a balanced asset structure.
Cash Flow
75
Positive
ALS has shown positive free cash flow growth of 4.58%, and the operating cash flow to net income ratio is healthy, indicating good cash generation relative to earnings. However, the free cash flow to net income ratio suggests room for improvement in cash conversion efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.19B3.00B2.46B2.28B1.95B1.76B
Gross Profit810.60M2.69B2.19B828.60M693.90M561.70M
EBITDA678.20M675.00M641.40M591.30M439.10M415.40M
Net Income271.10M256.20M12.90M291.20M190.50M169.60M
Balance Sheet
Total Assets4.11B4.06B3.70B3.33B2.84B2.48B
Cash, Cash Equivalents and Short-Term Investments211.20M268.00M299.90M179.60M122.80M168.60M
Total Debt1.76B2.09B1.87B1.45B1.24B967.70M
Total Liabilities2.43B2.77B2.50B1.95B1.71B1.40B
Stockholders Equity1.68B1.28B1.18B1.37B1.12B1.07B
Cash Flow
Free Cash Flow194.00M244.60M198.40M293.80M167.90M184.70M
Operating Cash Flow441.80M409.60M350.10M439.90M286.80M265.80M
Investing Cash Flow-253.50M-327.70M-226.80M-267.00M-405.90M-120.50M
Financing Cash Flow-251.40M-120.00M-3.10M-121.20M77.40M-379.90M

ALS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price22.12
Price Trends
50DMA
21.66
Positive
100DMA
20.40
Positive
200DMA
18.41
Positive
Market Momentum
MACD
0.06
Positive
RSI
57.13
Neutral
STOCH
51.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ALQ, the sentiment is Positive. The current price of 22.12 is above the 20-day moving average (MA) of 21.79, above the 50-day MA of 21.66, and above the 200-day MA of 18.41, indicating a bullish trend. The MACD of 0.06 indicates Positive momentum. The RSI at 57.13 is Neutral, neither overbought nor oversold. The STOCH value of 51.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ALQ.

ALS Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
AU$4.85B19.6942.87%3.64%1.48%25.46%
66
Neutral
AU$11.23B40.1518.38%1.77%18.18%4272.22%
65
Neutral
AU$2.64B31.0617.57%2.74%7.20%32.60%
64
Neutral
AU$5.27B38.966.66%3.14%-4.53%97.67%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
56
Neutral
AU$2.33B83.664.71%3.25%12.18%-73.81%
56
Neutral
AU$1.77B23.409.26%1.54%15.14%-7.23%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:ALQ
ALS
22.12
7.18
48.05%
AU:DOW
Downer EDI Limited
7.94
2.78
53.79%
AU:MND
Monadelphous Group Limited
26.40
13.58
105.93%
AU:NWH
NRW Holdings Limited
5.07
1.45
40.02%
AU:VNT
Ventia Services Group Limited
5.86
2.44
71.35%
AU:MGH
MAAS Group Holdings Ltd.
4.87
0.29
6.33%

ALS Corporate Events

ALS Limited Director Adjusts Shareholding for Tax Obligations
Dec 5, 2025

ALS Limited announced a change in the interest of its director, Malcolm Deane, who disposed of 7,356 ordinary shares through an on-market trade to meet taxation obligations. This transaction reduced Deane’s holding to 63,376 ordinary shares, while his performance and service rights remained unchanged. The disposal of shares is a routine adjustment for tax purposes and does not indicate any strategic shift or operational change within the company.

ALS Limited Announces H1 FY26 Financial Results and Reporting Changes
Nov 17, 2025

ALS Limited has released its H1 FY26 financial results for the six months ending September 30, 2025. The company has announced a reclassification of specific amounts in its financial reporting to provide a clearer representation of its core operating performance, starting in H2 FY26. This change aims to simplify the understanding of its financial results and enhance transparency for stakeholders.

ALS Reports Strong H1 FY26 Performance with Notable Growth in Commodities
Nov 17, 2025

ALS reported a strong financial performance for the first half of the fiscal year 2026, with a 14.7% increase in underlying EBIT and a 13.3% rise in revenue, driven by robust growth in the commodities sector. The company maintained resilient margins despite price discounting in previous quarters and achieved significant organic growth in its minerals and life sciences segments. ALS’s strategic capital deployment and balance sheet strength position it well for continued growth, with a declared interim dividend reflecting confidence in its financial health.

ALS Limited Announces Dividend Distribution for Shareholders
Nov 17, 2025

ALS Limited has announced a dividend distribution of AUD 0.194 per share for its ordinary fully paid shares, covering the six-month period ending September 30, 2025. The dividend will be paid on December 17, 2025, with an ex-date of November 26, 2025, and a record date of November 27, 2025, reflecting the company’s ongoing commitment to returning value to shareholders.

ALS Limited Releases Interim Financial Report for 2025
Nov 17, 2025

ALS Limited has released its condensed interim financial report for the half year ending 30 September 2025. The report provides a comprehensive overview of the company’s financial performance, including profit and loss, balance sheet, and cash flow statements. This release is crucial for stakeholders as it offers insights into the company’s operational efficiency and financial health during the period.

ALS Limited Addresses ASX Compliance Query on Performance Rights Lodgement
Nov 6, 2025

ALS Limited addressed a query from the ASX regarding the late lodgement of performance rights granted to Mr. Malcolm Deane. The company attributed the delay to human error within its Corporate Governance team and confirmed that necessary compliance procedures are in place. ALS has reviewed and enhanced its processes, embedding key regulatory obligations into new software and providing training to ensure future compliance. The company emphasizes its commitment to regulatory adherence and does not see the need for additional steps beyond enforcing existing protocols.

ALS Limited Announces Director’s Acquisition of Performance Rights
Nov 6, 2025

ALS Limited announced a change in the director’s interest, with Malcolm Deane acquiring 146,884 Performance Rights under the company’s 2025 Long-Term Incentive Plan, following shareholder approval at the 2025 AGM. This acquisition increases Deane’s total holdings and reflects ALS’s commitment to aligning executive interests with company performance, potentially impacting stakeholder confidence and the company’s market positioning.

ALS Limited Issues Unquoted Equity Securities for Employee Incentive
Oct 12, 2025

ALS Limited has announced the issuance of unquoted equity securities, specifically performance rights and service rights, as part of an employee incentive scheme. This move reflects ALS Limited’s ongoing commitment to employee engagement and retention, potentially enhancing its operational efficiency and market competitiveness.

ALS Limited Announces Issuance of Unquoted Equity Securities
Oct 12, 2025

ALS Limited has announced the issuance and conversion of unquoted equity securities, specifically ordinary fully paid shares, totaling 552,093 shares. This move reflects the company’s ongoing efforts to manage its capital structure and may impact its market positioning by potentially increasing liquidity and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025